Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-29 10:34 am Purchase |
2025-06-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 178,040 4.400% |
178,040 (New Position) |
Filing History |
| 2025-05-15 3:27 pm Purchase |
2025-03-31 | 13G | FibroGen, Inc. FGEN |
ARMISTICE CAPITAL LLC | 340,000 8.420% |
68,000 (+25.00%) |
Filing History |
| 2025-02-14 5:49 pm Unchanged |
2024-12-31 | 13G | FibroGen, Inc. FGEN |
ARMISTICE CAPITAL LLC | 272,000 6.750% |
0 (Unchanged) |
Filing History |
| 2025-02-13 6:24 pm Sale |
2024-12-31 | 13G | FibroGen, Inc. FGEN |
PRIMECAP MANAGEMENT CO | 184,645 4.580% |
-211,804 (-53.43%) |
Filing History |
| 2024-11-14 4:52 pm Sale |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
ARMISTICE CAPITAL LLC | 272,000 6.770% |
-118,560 (-30.36%) |
Filing History |
| 2024-11-12 4:01 pm Sale |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
PRIMECAP MANAGEMENT CO | 396,449 9.870% |
-182,428 (-31.51%) |
Filing History |
| 2024-11-12 2:33 pm Unchanged |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 235,294 5.850% |
0 (Unchanged) |
Filing History |
| 2024-11-04 1:08 pm Unchanged |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 235,294 5.850% |
0 (Unchanged) |
Filing History |
| 2024-11-04 12:11 pm Sale |
2024-09-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 235,294 5.850% |
-46,472 (-16.49%) |
Filing History |
| 2024-07-08 4:32 pm Sale |
2024-06-30 | 13G | FibroGen, Inc. FGEN |
BlackRock Inc. BLK |
96,386 2.400% |
-191,826 (-66.56%) |
Filing History |
| 2024-02-14 3:37 pm Purchase |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
ARMISTICE CAPITAL LLC | 390,560 9.930% |
390,560 (New Position) |
Filing History |
| 2024-02-14 10:04 am Sale |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
Point72 Asset Management, L.P. | 65,754 1.700% |
-185,512 (-73.83%) |
Filing History |
| 2024-02-13 5:04 pm Sale |
2023-12-29 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 281,766 7.160% |
-95,997 (-25.41%) |
Filing History |
| 2024-02-12 4:01 pm Purchase |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
PRIMECAP MANAGEMENT CO | 578,877 14.720% |
23,074 (+4.15%) |
Filing History |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | FibroGen, Inc. FGEN |
BlackRock Inc. BLK |
288,212 7.300% |
2,862 (+1.00%) |
Filing History |
| 2023-07-19 4:47 pm Purchase |
2023-07-13 | 13G | FibroGen, Inc. FGEN |
Millennium Management LLC | 183,513 4.700% |
183,513 (New Position) |
Filing History |
| 2023-02-14 4:22 pm Purchase |
2022-12-31 | 13G | FibroGen, Inc. FGEN |
Point72 Asset Management, L.P. | 251,266 6.700% |
64,622 (+34.62%) |
Filing History |
| 2023-02-09 4:01 pm Purchase |
2022-12-31 | 13G | FibroGen, Inc. FGEN |
PRIMECAP MANAGEMENT CO | 555,803 14.790% |
36,238 (+6.97%) |
Filing History |
| 2023-02-09 11:19 am Purchase |
2022-12-30 | 13G | FibroGen, Inc. FGEN |
The Vanguard Group | 377,763 10.050% |
2,355 (+0.63%) |
Filing History |
| 2023-02-08 10:05 am Sale |
2022-12-31 | 13G | FibroGen, Inc. FGEN |
First Trust Portfolios L.P. | 119,026 3.170% |
-93,678 (-44.04%) |
Filing History |